# Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/treatment-related-adverse-events-of-pd-1-and-pd-l1-inhibitors-in-clinical-trials/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yucai Wang,Shouhao Zhou,Fang Yang,Xinyue Qi,Xin Wang,Xiaoxiang Guan,Chan Shen,Narjust Duma,Jesus Vera Aguilera,Ashish V. Chintakuntlawar,Katharine A. Price,Julian R. Molina,Lance C. Pagliaro,Þorvarður R. Hálfdánarson,Axel Grothey,Svetomir N. Markovic,Grzegorz S. Nowakowski,Stephen M. Ansell,Michael Wang |
| Citations | 860 |
| DOI | 10.1001/jamaoncol.2019.0393 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://jamanetwork.com/journals/jamaoncology/articlepdf/2731143/jamaoncology_wang_2019_oi_190016.pdf |
| OpenAlex ID | https://openalex.org/W2940759533 |
| PMID | 31021376 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Þorvarður R. Hálfdánarson](https://scholariq.org/researchers/orvar-ur-r-halfdanarson/)

## Paper journal

- [JAMA Oncology](https://scholariq.org/journals/jama-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Drug-Induced Adverse Reactions](https://scholariq.org/topics/drug-induced-adverse-reactions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.